SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-027644
Filing Date
2021-05-13
Accepted
2021-05-13 17:20:53
Documents
54
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q avir-10q_20210331.htm 10-Q 1753998
2 EX-31.1 avir-ex311_6.htm EX-31.1 19858
3 EX-31.2 avir-ex312_8.htm EX-31.2 19681
4 EX-32.1 avir-ex321_7.htm EX-32.1 9394
5 EX-32.2 avir-ex322_9.htm EX-32.2 9410
  Complete submission text file 0001564590-21-027644.txt   4019161

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT avir-20210331.xml EX-101.INS 501786
7 XBRL TAXONOMY EXTENSION SCHEMA avir-20210331.xsd EX-101.SCH 33454
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE avir-20210331_cal.xml EX-101.CAL 30850
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE avir-20210331_def.xml EX-101.DEF 63664
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE avir-20210331_lab.xml EX-101.LAB 229908
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avir-20210331_pre.xml EX-101.PRE 170787
Mailing Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110
Business Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110 857-204-8109
Atea Pharmaceuticals, Inc. (Filer) CIK: 0001593899 (see all company filings)

IRS No.: 460574869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39661 | Film No.: 21920827
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences